INS and type 2 diabetes mellitus: Moreover, the oral administration of the insulin-bearing recombinant GM4-ΔTS-PGK1-CCT-insulin strain in type II diabetes mellitus mice significantly reduced blood glucose levels in vivo, indicating that the recombinant strain we constructed successfully carries the exogenous polypeptide into the body.